Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.24NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.320NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.320NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
C.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.33NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.635NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.635NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
C.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.21NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
C.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.14NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.1.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.15NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.1.14.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.14.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.1.14.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.14.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.1 (Omicron)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1 (Omicron)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.1.17.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.17.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.99.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.99.2 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.3 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.18.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.18.7NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
MB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MB.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
LE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LE.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
XBB.1.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
LE.1.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LE.1.3.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XDR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDR.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.49.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.49.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
EG.5.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HV.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.6NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.16.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.11NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.293NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.293NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.225NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.225NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.637NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used